Results 101 to 110 of about 3,123 (163)

Clinical outcomes of dalbavancin versus standard therapy for non-severe skin and soft-tissue infections as well as bone and joint infections: a retrospective observational study. [PDF]

JAC Antimicrob Resist
Kitano T, Tsuzuki S, Yoshida S.
europepmc   +1 more source

A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians). [PDF]

JAC Antimicrob Resist
Rabbione A, Petri F, Civati A, Mariani C, Landonio S, Scandiffio L, Giorgi R, Foschi A, Offer M, Cossu MV, Tande AJ, Cattaneo D, Dolci A, Suh GA, Gori A, Passerini M.   +15 more
europepmc   +1 more source

Optimizing Treatment of Infective Endocarditis in Patients Who Inject Drugs. [PDF]

Antibiotics (Basel)
Worden J, Baumeister T, Eaton E.
europepmc   +1 more source

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections. [PDF]

J Antimicrob Chemother
Hugg R, Stegger M, Söderquist B.
europepmc   +1 more source

Dalbavancin in the Real-World Management of Gram-Positive Infections: A Systematic Review of Randomized and Observational Studies. [PDF]

Microorganisms
Tana C, Moffa L, Tana M, Moffa S, Ucciferri C.   +4 more
europepmc   +1 more source

Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy. [PDF]

Antimicrob Agents Chemother
Sayadi H, Gregoire M, Fromage Y, Labriffe M, Maizaud F, Monchaud C, Codde C, Boutoille D, Marquet P, Woillard J-B.   +9 more
europepmc   +1 more source

Saving Beds and Budgets: Real-World Efficacy, Safety, and Pharmacoeconomics of Long-Acting Lipoglycopeptides (LALs) in a Day Hospital Setting. [PDF]

Pathogens
Marino A, Venanzi Rullo E, Pipitone G, Geremia AG, De Vito A, Albanese A, Geremia N, Franzò A, Cosentino F, Italia P, Ciuppa ME, Buzzi A, Santoro L, Iaria C, Madeddu G, Iacobello C, Manuele R, Pulvirenti F, Cacopardo B, Nunnari G.   +19 more
europepmc   +1 more source

Stewardship Challenges, PK/PD Evidence, and Prescribing Appropriateness for Recently Approved Antibiotics in Pediatric Practice. [PDF]

Antibiotics (Basel)
Romandini A, Resnati C, Crucitta S, Agliardi S, D'Amico F, Pattarino GAC, Altieri E, Danesi R, De Giacomo C.   +8 more
europepmc   +1 more source

Real-World Effectiveness of Dalbavancin in Osteomyelitis Without Implantable Devices: A Retrospective Monocentric Study. [PDF]

Antibiotics (Basel)
Tiecco G, Lenzi A, Cesanelli F, Van Hauwermeiren E, Rossini F, Sollima A, Mulé A, Lorenzotti S, Signorini L, Castelli F, Quiros-Roldan E.   +10 more
europepmc   +1 more source

Proactive Therapeutic Drug Monitoring of Dalbavancin in the Long-Term Treatment of Chronic Infections: A Narrative Review. [PDF]

Antibiotics (Basel)
Cattaneo D, Cusato J.
europepmc   +1 more source